Betaine

Betaine

SCHEMBL4254026

CCCCCCCCCCCC[N+](C)(C)CC(O)CS(=O)(=O)O.C[N+](C)(C)CC(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BHMTBHMT2

The experimentally established mechanism targets of Betaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PSMD14 O00487 2/20 0.43
PLA2G1B P04054 2/20 0.43
MMP2 P08253 2/20 0.43
ATG4B Q9Y4P1 2/20 0.43
HSP90AA1 P07900 1/20 0.43
TSHR P16473 1/20 0.37
HTT P42858 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
APEX1 P27695 1/20 0.36
GPR84 Q9NQS5 4/20 0.36
DNM1 Q05193 5/20 0.35
FFAR4 Q5NUL3 1/20 0.35
FFAR1 O14842 1/20 0.35
RAD52 P43351 1/20 0.35
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11770996 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL6242053 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL6237613 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL10935342 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL1104430 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL10934245 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL10937702 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL10934552 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL10933452 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
SCHEMBL10937597 0.89 PLA2G1B (0.53) PSMD14PLA2G1BMMP2ATG4BHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984121-B1 NON-LEACHING SURFACE-ACTIVE FILM COMPOSITIONS FOR MICROBIAL ADHESION PREVENTION HYDROMER INC (US) 2019-05-08 EP claimed
JP-2009523890-A 2009-06-25 JP claimed
EP-1984121-A2 NON-LEACHING SURFACE-ACTIVE FILM COMPOSITIONS FOR MICROBIAL ADHESION PREVENTION Hydromer, Inc. (US) 2008-10-29 EP claimed
WO-2007084452-A2 NON-LEACHING SURFACE-ACTIVE FILM COMPOSITIONS FOR MICROBIAL ADHESION PREVENTION HYDROMER, INC. (US) 2007-07-26 WO claimed
US-20070166344-A1 Non-leaching surface-active film compositions for microbial adhesion prevention HYDROMER, INC. 2007-07-19 US claimed
EP-1984121-B1 NON-LEACHING SURFACE-ACTIVE FILM COMPOSITIONS FOR MICROBIAL ADHESION PREVENTION HYDROMER INC (US) 2019-05-08 EP disclosed
EP-1984121-A2 NON-LEACHING SURFACE-ACTIVE FILM COMPOSITIONS FOR MICROBIAL ADHESION PREVENTION Hydromer, Inc. (US) 2008-10-29 EP disclosed
WO-2007084452-A2 NON-LEACHING SURFACE-ACTIVE FILM COMPOSITIONS FOR MICROBIAL ADHESION PREVENTION HYDROMER, INC. (US) 2007-07-26 WO disclosed
US-20070166344-A1 Non-leaching surface-active film compositions for microbial adhesion prevention HYDROMER, INC. 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070166344-A1 Non-leaching surface-active film compositions for microbial adhesion prevention ICAM1, CD44, NONO PSMD14 1570/4885PLA2G1B 3873/4885MMP2 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.